Cargando…

Analysis of risk factors of hepatocellular carcinoma and establishment of a clinical prognosis model

Liver cancer is a common malignancy of the digestive system. Hepatocellular carcinoma (HCC) accounts for the most majority of these tumors and it has brought a heavy medical burden to underdeveloped countries and regions. Many factors affect the prognosis of HCC patients, however, there is no specif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ge, Xin-Yu, Sun, Ming-Chen, Wang, Tian-Yi, Wang, Xi-Min, Liu, Gang, Yang, Tao, Lu, Yi-Ming, Wang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073455/ https://www.ncbi.nlm.nih.gov/pubmed/37035138 http://dx.doi.org/10.3389/fonc.2023.1067353

Ejemplares similares

Characterization of chromatin regulators identified prognosis and heterogeneity in hepatocellular carcinoma
por: Dai, Yin-wei, et al.
Publicado: (2022)

Integration of Inflammation-Immune Factors to Build Prognostic Model Predictive of Prognosis and Minimal Residual Disease for Hepatocellular Carcinoma
por: Xu, Xin, et al.
Publicado: (2022)

Up-Regulation of hsa_circ_0000517 Predicts Adverse Prognosis of Hepatocellular Carcinoma
por: Wang, Xicheng, et al.
Publicado: (2019)

An anoikis-related gene signature predicts prognosis and reveals immune infiltration in hepatocellular carcinoma
por: Chen, Yang, et al.
Publicado: (2023)

Progress of MRI Radiomics in Hepatocellular Carcinoma
por: Gong, Xue-Qin, et al.
Publicado: (2021)

A macropinocytosis-related gene signature predicts the prognosis and immune microenvironment in hepatocellular carcinoma
por: Ding, Xinjiang, et al.
Publicado: (2023)

Establishment and validation of nomogram model for the diagnosis of AFP-negative hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2023)

Radiomics-based nomogram as predictive model for prognosis of hepatocellular carcinoma with portal vein tumor thrombosis receiving radiotherapy
por: Huang, Yu-Ming, et al.
Publicado: (2022)

Glutamine Metabolism Scoring Predicts Prognosis and Therapeutic Resistance in Hepatocellular Carcinoma
por: Ying, Leqian, et al.
Publicado: (2021)

Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma
por: Li, Tian-Hao, et al.
Publicado: (2021)

Four circadian rhythm-related genes predict incidence and prognosis in hepatocellular carcinoma
por: Wu, Zhenyu, et al.
Publicado: (2022)

Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
por: Zhang, Xinhe, et al.
Publicado: (2021)

SKA1/2/3 is a biomarker of poor prognosis in human hepatocellular carcinoma
por: Song, Guo-Qiang, et al.
Publicado: (2022)

Genetic testing and prognosis of sarcomatoid hepatocellular carcinoma patients
por: Jia, Bin, et al.
Publicado: (2023)

A Novel Multimodal Radiomics Model for Predicting Prognosis of Resected Hepatocellular Carcinoma
por: He, Ying, et al.
Publicado: (2022)

Identification of cuprotosis-mediated subtypes, the development of a prognosis model, and influence immune microenvironment in hepatocellular carcinoma
por: Xiao, Jingjing, et al.
Publicado: (2022)

Emerging Perspectives of Bone Metastasis in Hepatocellular Carcinoma
por: Yuan, Xiaofeng, et al.
Publicado: (2022)

Elevated Small Nuclear Ribonucleoprotein Polypeptide an Expression Correlated With Poor Prognosis and Immune Infiltrates in Patients With Hepatocellular Carcinoma
por: Zhang, Youfu, et al.
Publicado: (2022)

Establishment and validation of a clinicopathological prognosis model of gastroenteropancreatic neuroendocrine carcinomas
por: Chen, Jing, et al.
Publicado: (2022)

Advances of Targeted Therapy for Hepatocellular Carcinoma
por: Niu, Mengke, et al.
Publicado: (2021)

Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma
por: Zheng, Xiufeng, et al.
Publicado: (2022)

Establishment of a prognosis Prediction Model Based on Pyroptosis-Related Signatures Associated With the Immune Microenvironment and Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2021)

Comprehensive Analysis of Immune-Related Prognosis of TK1 in Hepatocellular Carcinoma
por: Cai, Qun, et al.
Publicado: (2022)

Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)

Establishment of a Prognostic Model for Hepatocellular Carcinoma Based on Endoplasmic Reticulum Stress-Related Gene Analysis
por: Liu, Peng, et al.
Publicado: (2021)

Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Kainan, et al.
Publicado: (2021)

Establishment of a Novel Risk Score System of Immune Genes Associated With Prognosis in Esophageal Carcinoma
por: Fei, Zhenghua, et al.
Publicado: (2021)

Deep Learning for Approaching Hepatocellular Carcinoma Ultrasound Screening Dilemma: Identification of α-Fetoprotein-Negative Hepatocellular Carcinoma From Focal Liver Lesion Found in High-Risk Patients
por: Zhang, Wei-bin, et al.
Publicado: (2022)

A novel nomogram based on GD for predicting prognosis in hepatocellular carcinoma
por: Liu, Ying, et al.
Publicado: (2023)

The Ribosomal Protein L28 Gene Induces Sorafenib Resistance in Hepatocellular Carcinoma
por: Shi, Yi, et al.
Publicado: (2021)

A New Clinical Nomogram From the TCGA Database to Predict the Prognosis of Hepatocellular Carcinoma
por: Ye, Dingde, et al.
Publicado: (2021)

The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis
por: Zhao, Xueying, et al.
Publicado: (2022)

Prognosis and Risk Factors of Recurrence in HBV-Related Small Hepatocellular Carcinoma After Stereotactic Body Radiation Therapy
por: Han, Yifan, et al.
Publicado: (2022)

Establishment of a Novel Mouse Hepatocellular Carcinoma Model for Dynamic Monitoring of Tumor Development by Bioluminescence Imaging
por: Cao, Xiangyi, et al.
Publicado: (2022)

A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma
por: Chen, Yongwei, et al.
Publicado: (2023)

Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Kainan, et al.
Publicado: (2021)

Associations of DDX60L With the Clinical Features and Prognosis of Hepatocellular Carcinoma
por: Ye, Ziqi, et al.
Publicado: (2022)

RNF135 Promoter Methylation Is Associated With Immune Infiltration and Prognosis in Hepatocellular Carcinoma
por: Wang, Xiao, et al.
Publicado: (2022)

Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma
por: He, Yixian, et al.
Publicado: (2023)

Imaging Features of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: A Multicenter Study
por: Wu, Jun-Yi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i8pieqrc8uqdsffjffo3t6vkl9